EPISODE · Jan 21, 2026 · 1H 1M
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
from Oncology Today with Dr Neil Love
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.CME information and select publications here.
NOW PLAYING
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m